TGFB1 and atrial fibrillation: As illustrated in Figure 4, patients with AF exhibit significantly elevated serum concentrations of ADMA (P < 0.01, Figure 4A), TGF-β1 (P < 0.001, Figure 4B) and decreased NO (P < 0.01, Figure 4C) compared to control subjects.